- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Close Asset Management Ltd Trims McKesson Holdings
Institutional investor reduces stake in pharmaceutical distributor by 77.5%
Published on Feb. 27, 2026
Got story updates? Submit your updates here. ›
Close Asset Management Ltd, an institutional investor, has trimmed its position in McKesson Corporation (NYSE:MCK) by 77.5% in the third quarter, according to a recent SEC filing. The firm now owns 43,326 shares of the company's stock, valued at $33,480,000 at the end of the quarter.
Why it matters
McKesson is a major pharmaceutical distributor and healthcare services company, so changes in institutional ownership of its stock can provide insights into market sentiment and expectations around the company's performance.
The details
Close Asset Management Ltd sold 148,989 shares of McKesson stock during the third quarter, reducing its total holdings to 43,326 shares. The firm cited portfolio rebalancing and risk management as reasons for the reduction in its McKesson position.
- Close Asset Management Ltd filed its SEC report on the McKesson position change in the third quarter of 2026.
The players
Close Asset Management Ltd
An institutional investor that manages a portfolio of stocks, including a position in pharmaceutical distributor McKesson Corporation.
McKesson Corporation
A global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions.
The takeaway
This reduction in Close Asset Management's McKesson holdings reflects broader market trends and investor sentiment around the pharmaceutical distribution industry, which faces ongoing challenges around drug pricing, supply chain issues, and regulatory changes.
